<DOC>
	<DOCNO>NCT01864083</DOCNO>
	<brief_summary>This study design help u determine FACBC PET PEM accurately evaluate far breast cancer spread breast . Also , help determine FACBC PET PEM accurately measure response chemotherapy .</brief_summary>
	<brief_title>FACBC PET PEM Staging Tool Indicator Therapeutic Response Breast Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Women present evaluation MSKCC biopsy proven primary IDC ILC No prior therapy IDC ILC Clinical need local disease stag breast MR ( Group A ) Clinical need neoadjuvant chemotherapy ( Group B ) Patients must provide write informed consent Age &lt; 21 year Men Pregnancy lactation Patients already start treatment current malignancy Patients undergo PET scanning ( i.e . weight limit ) Patients know contraindication MRI ( e.g . metal implant ) Patients may participate group # 1 group # 2 ,</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>FACBC PET/PEM</keyword>
	<keyword>MR</keyword>
	<keyword>11-177</keyword>
</DOC>